It's amazing that our government would depend on a private panel of biased doctors to have any input at all into a coverage decision. They created their own loophole to dive through. It explains a lot about our skyrocketing health care costs doesn't it. Maybe they should have read ObamaCare before they voted on it. It sure hits home at the overall lack of progress in CRC care for the past 30 years. Essentially, a death panel of people Preventing Service as they protect their own interests and the status quo. They should all resign in shame immediately. Totally un-American like Whitey Shillson.
Sentiment: Strong Buy
Ran....almost nothing has changed. I wasn't a fan of the Doyle Square project (understatement), and I think it is a net positive for shareholders, that it is not happening. The Prevent Service Task Fools did send out a curve ball, and clearly shorty knew it. I don't know that it will slow things that much, as everyone I know over 50, which is getting to be pretty much everyone I know, has talked to their doctor about Cologuard already, or their doctor has talked to them about it if they are in for a Colonoscopy. Insurers were already picking up at a rapid pace, so maybe that slows a little based on the incoherent opinion of the Task Fools, but I see a marginal effect. I see profitability by sometime in 2017, which is pretty much what I've felt for the past five years. Don't see it changing a whole lot. Meanwhile, we put up with a collection of hedge funds playing the short low float Biotech game until it becomes clear to everyone when profitability will come into view. Its amazing our government set up a trading system that allows a handful of people with more money than brains or morals to inhibit the growth of companies by inhibiting their ability to raise capital and grow out their life saving products. A few people trying to pocket a few hundred million while 50,000 people a year are dying from CRC alone and taxpayers on the hook for another $14 billion in late stage treatment expense. It shows you can't fix stupid, but you can buy it. GL.
Sentiment: Strong Buy
Three posts from the same moron under three different ID's, and all false. Congrats on your stupid. Come up with some new material please Mrs. Paid FUDster.
Sentiment: Strong Buy
Exactly. This is a patient and doctor driven product, and thankfully doesn't depend on a panel of bureaucrats who didn't even do their due diligence on the product before Preventing Service.
I sold half up their nit twit. I bought puts as usual before our most recent binary event. I also bought in the low single digits. When you factor in Shytty Wilsons cabal has to buy 30 million shares back, which will drive the share price right back to $20 where it belongs, I'd say your grasping at straws. I've been correct from day one, and it wasn't the first time I flipped it either. Being one of the more recent paid FUD morons on this board, I wouldn't expect you to know that. Being you are a paid message board failure at life, I wouldn't expect you to know anything. Take a good look at the guy giving you a paycheck. It should be a mirror image of you. A low life blood sucker that produces nothing of value to anyone. FO.
Says another message board clown I had to unhide to read more garbage from. There's nothing left to be said as the patient demand for the product and lab tech hiring by the company says it all. Which I've also stated many times. I wouldn't expect a group of dolts who simply pool their money and try to step on companies financially via collusion and insider trading to have the slightest understanding, or care. Why would you?
Oh...I'll be ready Shytty Wilson. It's called large distribution spells large buy of incredibly undervalued company. Space ship ride number two. Tick tock.......
There have been dozens of projections plastered on this board over the years. If you haven't done some type of projection on estimated sales break even, and future profitability on this company, or any other you are involved with, I'd suggest mutual funds and bonds for you. This is nothing more than the classic short cabals attempt to hold everyone's head under water until they have to come up for air. It's probably why the only longs left on this board were in well before the FUD spewers showed up. I'll be here long after the crooks have moved on, too.
So....in conclusion....you remain nothing but a dim witted message board clown working for Shytty Wilson.
I think they have pretty good idea what test results are going to say don't you think. Or, do think people sit around and go "Hey, I know, why don't we try out a few markers and $100 million on this and you know, see what happens??" You guys are good for a solid laugh, I'll give you that.
Lay off a sales effort so you can count your money?? LMAO! Any company, including my own, can hire bean counters all day long to count money while the rest of the organization continues to do its job handling the "multiple variables" involved in running a business. What a sham FUD tool box you are. I'd rather drop my drawers and go out and pick up quarters on State Street than share projections on this board.
I think you mean Shytty Wilson, the guy who had a plant on the US Prevent Service Task Fool panel, that was clearly leaking the draft document information to him, which is why he wasn't covering. The SEC should bury this guy in the deepest hole they can find.
No Dumb biasturd....I was the one buying in the low single digits while a collection of "big money" nitwits bought hundreds of millions of the stock at those prices, so another collection of Crime Street crooks could sell it short and hire nitwits like you to spread FUD all day. At least you could come up with some new material. A monkey could do your job.
Cologuard has the compliance rate of any of the aforementioned tests. Not even close. The number of new doctors prescribing the test is outstanding for a new test with growing insurance coverage. The number of new doctors prescribing multiple tests is also growing at an excellent rate. If you can't do a simple present value future worth calculation based on the accelerating growth rate to come up with a fair market value, you should have went to a better school. EXAS will be profitable long before they run out of cash. If they sell some more stock along the way, so be it. That's the biotech industry. Maybe you should buy some utility stocks.
Sentiment: Strong Buy
The haggling is over and the test costs in the neighborhood of $144 to complete. Once, the roll out is complete they will make money hand over fist. They rushed the last offering to stay ahead of market forces....I mean market crooks on Crime Street. Smart move. Clearly, better informed than you punks.
Yes, but apparently the U.S. Prevent Service Task Fools would rather protect the status quo low compliance complete fail colonoscopy/FIT/late stage surgery market. They look at it like there sales market is shrinking $ 6.4 billion.